المؤلفون: Garg A; Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada., Nanji K; Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Tai F; Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada., Phillips M; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Zeraatkar D; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Garg SJ; Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USA., Sadda SR; Department of Ophthalmology, David Geffen School of Medicine at University of California, Los Angeles, CA, USA; Doheny Eye Institute, Los Angeles, CA, USA., Kaiser PK; Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA., Guymer RH; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia; Department of Surgery (Ophthalmology), University of Melbourne, Melbourne, Australia., Sivaprasad S; Institute of Ophthalmology, University College London, UK; NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK., Wykoff CC; Retina Consultants of Texas, Houston, TX, USA; Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA., Chaudhary V; Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada. Electronic address: vchaudh@mcmaster.ca.

المصدر: Survey of ophthalmology [Surv Ophthalmol] 2024 May-Jun; Vol. 69 (3), pp. 349-361. Date of Electronic Publication: 2023 Nov 24.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0404551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3304 (Electronic) Linking ISSN: 00396257 NLM ISO Abbreviation: Surv Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Complement C3*/metabolism , Complement C3*/antagonists & inhibitors , Complement C5*/antagonists & inhibitors , Complement Inactivating Agents*/therapeutic use , Geographic Atrophy*/drug therapy , Geographic Atrophy*/diagnosis , Geographic Atrophy*/etiology , Geographic Atrophy*/physiopathology, Humans ; Macular Degeneration/drug therapy ; Visual Acuity

المؤلفون: Shangguan W; School of Pharmacy, Fudan University, 201203 Shanghai, China.; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China., Li X; School of Pharmacy, Fudan University, 201203 Shanghai, China.; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China., Wang Y; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China.; Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, 310014 Hangzhou, China., Huang Z; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China.; Shanghai Duomirui Biotechnology Co Ltd, 201203 Shanghai, China., Dong Y; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China.; Shanghai Duomirui Biotechnology Co Ltd, 201203 Shanghai, China., Feng M; School of Pharmacy, Fudan University, 201203 Shanghai, China., Feng J; Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China.

المصدر: Bioconjugate chemistry [Bioconjug Chem] 2024 May 15; Vol. 35 (5), pp. 653-664. Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9010319 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4812 (Electronic) Linking ISSN: 10431802 NLM ISO Abbreviation: Bioconjug Chem Subsets: MEDLINE

مواضيع طبية MeSH: Fatty Acids*/chemistry , Ornithodoros* , Complement C5*/antagonists & inhibitors, Animals ; Mice ; Drug Design ; Half-Life ; Complement Inactivator Proteins/pharmacology ; Complement Inactivator Proteins/chemistry ; Complement Inactivating Agents/pharmacology ; Complement Inactivating Agents/pharmacokinetics ; Complement Inactivating Agents/chemistry ; Humans

المؤلفون: Ardissino G; Center for HUS Prevention, Control and Management at the Pediatric Nephrology, Dialysis and Transplantation Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via della Commenda 9, 20122, Milan, Italy. ardissino@centroseu.org., Cresseri D; Center for HUS Prevention, Control and Management at the Nephrology and Dialysis Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Mancuso MC; Center for HUS Prevention, Control and Management at the Pediatric Nephrology, Dialysis and Transplantation Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via della Commenda 9, 20122, Milan, Italy., Capone V; Center for HUS Prevention, Control and Management at the Pediatric Nephrology, Dialysis and Transplantation Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via della Commenda 9, 20122, Milan, Italy., Porcaro L; Medical Genetics Laboratory, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy., Amico V; Medical Genetics Laboratory, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy., Tangredi M; Center for HUS Prevention, Control and Management at the Nephrology and Dialysis Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Grovetti E; Medicina Interna Dipartimento di Fisiopatologia Medico‑Chirurgica e dei Trapianti, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy., Griffini S; Medicina Interna Dipartimento di Fisiopatologia Medico‑Chirurgica e dei Trapianti, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy., Castellano G; Center for HUS Prevention, Control and Management at the Nephrology and Dialysis Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Montini G; Pediatric Nephrology, Dialysis and Transplantation Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Giuliana and Bernardo Caprotti Chair of Pediatrics, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Consonni D; Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Cugno M; Medicina Interna Dipartimento di Fisiopatologia Medico‑Chirurgica e dei Trapianti, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.

مؤلفون مشاركون: HUS-ItalKid Network.

المصدر: Journal of nephrology [J Nephrol] 2024 May; Vol. 37 (4), pp. 1017-1026. Date of Electronic Publication: 2024 Jan 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Italy NLM ID: 9012268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1724-6059 (Electronic) Linking ISSN: 11218428 NLM ISO Abbreviation: J Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Atypical Hemolytic Uremic Syndrome*/drug therapy , Antibodies, Monoclonal, Humanized*/therapeutic use , Complement C5*/antagonists & inhibitors, Humans ; Male ; Female ; Adult ; Treatment Outcome ; Kidney Failure, Chronic/etiology ; Complement Inactivating Agents/therapeutic use ; Retrospective Studies ; Adolescent ; Young Adult ; Recurrence ; Middle Aged ; Complement Activation/drug effects ; Child ; Risk Factors ; Time Factors

المصدر: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2024 Apr 15; Vol. 66 (1700), pp. 60-62.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN: 1523-2859 (Electronic) Linking ISSN: 0025732X NLM ISO Abbreviation: Med Lett Drugs Ther Subsets: MEDLINE

مواضيع طبية MeSH: Myasthenia Gravis*/diagnosis , Myasthenia Gravis*/drug therapy , Complement C5* , Peptides, Cyclic*, Humans ; Immunosuppressive Agents

المؤلفون: Kulasekararaj AG; King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London., Lehtinen AE; Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki., Forsyth C; Gosford Hospital, Gosford, NSW., Gandhi S; King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London., Griffin M; St. James's University Hospital, Leeds., Körper S; University of Ulm, Institute of Transfusion Medicine, and Institute of Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm., Mikala G; Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Budapest., Muus P; King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London, UK; St. James's University Hospital, Leeds., Overgaard U; University Hospital Copenhagen, Copenhagen, Denmark., Patriquin CJ; University Health Network, Toronto, ON., Pullon H; Waikato Hospital, Hamilton., Shen YM; UT Southwestern Medical Center, Dallas, TX., Spearing R; Christchurch Hospital, Christchurch., Szer J; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC., De la Borderie G; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC., Duda PW; UCB Pharma, Cambridge, MA., Farzaneh-Far R; UCB Pharma, Cambridge, MA., Ragunathan S; UCB Pharma, Cambridge, MA., Sayegh CE; UCB Pharma, Cambridge, MA., Vadysirisack DD; UCB Pharma, Cambridge, MA., Schrezenmeier H; University of Ulm, Institute of Transfusion Medicine, and Institute of Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm. h.schrezenmeier@blutspende.de.

المصدر: Haematologica [Haematologica] 2024 Mar 01; Vol. 109 (3), pp. 929-935. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Clinical Trial, Phase II; Letter

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Complement C5*/therapeutic use , Hemoglobinuria, Paroxysmal*/drug therapy , Peptides, Cyclic*/therapeutic use, Humans

المؤلفون: Jindal S; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Pedersen DV; Department of Molecular Biology and Genetics, Universitetsbyen 83, Aarhus University, Aarhus, Denmark., Gera N; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Chandler J; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Patel R; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Neill A; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Cone J; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Zhang Y; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Yuan CX; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Millman EE; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Carlin D; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA. Electronic address: Dan.Carlin@alexion.com., Puffer B; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Sheridan D; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA., Andersen GR; Department of Molecular Biology and Genetics, Universitetsbyen 83, Aarhus University, Aarhus, Denmark., Tamburini P; Alexion, AstraZeneca Rare Disease, 100 College Street, New Haven, CT 06510, USA.

المصدر: Molecular immunology [Mol Immunol] 2024 Jan; Vol. 165, pp. 29-41. Date of Electronic Publication: 2023 Dec 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7905289 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9142 (Electronic) Linking ISSN: 01615890 NLM ISO Abbreviation: Mol Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Complement C5* , Single-Domain Antibodies*, Humans ; Complement System Proteins/metabolism ; Complement Activation ; Albumins

المؤلفون: Liu A; Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital of Sun Yat-sen University, Shennan Middle Rd, Shenzhen, 518000, China., Chen Z; Department of Nephrology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518000, China., Li X; Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital of Sun Yat-sen University, Shennan Middle Rd, Shenzhen, 518000, China., Xie C; Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital of Sun Yat-sen University, Shennan Middle Rd, Shenzhen, 518000, China., Chen Y; Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital of Sun Yat-sen University, Shennan Middle Rd, Shenzhen, 518000, China., Su X; Department of Nephropathy, Tungwah Hospital of Sun Yat-Sen University, Dongguan, 523000, China., Chen Y; Department of Nephropathy, Tungwah Hospital of Sun Yat-Sen University, Dongguan, 523000, China., Zhang M; Department of Nephropathy, Tungwah Hospital of Sun Yat-Sen University, Dongguan, 523000, China., Chen J; Department of Radiotherapy, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, 510000, China., Yang T; Department of Nephrology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518000, China., Shen J; School of Chinese Medicine, Li Ka Shing Faculty of Medicine, State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, 999077, China., Huang H; Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital of Sun Yat-sen University, Shennan Middle Rd, Shenzhen, 518000, China.

المصدر: Cardiovascular research [Cardiovasc Res] 2023 Nov 25; Vol. 119 (15), pp. 2563-2578.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases* , Endoplasmic Reticulum Stress* , Vascular Calcification*/pathology , Complement C5*/metabolism, Animals ; Mice ; Calcium ; Cross-Sectional Studies ; Eukaryotic Initiation Factor-2/metabolism ; Eukaryotic Initiation Factor-2/pharmacology ; Signal Transduction

المؤلفون: Tang GQ; UCB Pharma, Cambridge, MA, United States., Tang Y; UCB Pharma, Cambridge, MA, United States., Dhamnaskar K; Ra Pharmaceuticals, Cambridge, MA, United States., Hoarty MD; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States., Vyasamneni R; Ra Pharmaceuticals, Cambridge, MA, United States., Vadysirisack DD; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States., Ma Z; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States., Zhu N; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States., Wang JG; UCB Pharma, Cambridge, MA, United States., Bu C; UCB Pharma, Cambridge, MA, United States., Cong B; UCB Pharma, Cambridge, MA, United States., Palmer E; UCB Pharma, Cambridge, MA, United States., Duda PW; UCB Pharma, Cambridge, MA, United States., Sayegh C; UCB Pharma/Ra Pharmaceuticals, Cambridge, MA, United States., Ricardo A; Ra Pharmaceuticals, Cambridge, MA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2023 Aug 09; Vol. 14, pp. 1213920. Date of Electronic Publication: 2023 Aug 09 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Complement Activation* , Complement C5*/antagonists & inhibitors , Hemolysis*, Humans ; Antibodies, Monoclonal

المؤلفون: Struijf EM; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., De la O Becerra KI; Structural Biochemistry Group, Faculty of Science, Department of Chemistry, Bijvoet Centre for Biomolecular Research, Utrecht University, Utrecht, The Netherlands., Ruyken M; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., de Haas CJC; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Oosterom F; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Siere DY; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Keulen JE; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Heesterbeek DAC; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Dolk E; QVQ Holding BV, Utrecht, The Netherlands., Heukers R; QVQ Holding BV, Utrecht, The Netherlands., Bardoel BW; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Gros P; Structural Biochemistry Group, Faculty of Science, Department of Chemistry, Bijvoet Centre for Biomolecular Research, Utrecht University, Utrecht, The Netherlands., Rooijakkers SHM; Department Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Electronic address: s.h.m.rooijakkers@umcutrecht.nl.

المصدر: The Journal of biological chemistry [J Biol Chem] 2023 Aug; Vol. 299 (8), pp. 104956. Date of Electronic Publication: 2023 Jun 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal* , Complement C5*/antagonists & inhibitors , Complement C5*/genetics , Single-Domain Antibodies*, Humans ; Complement Activation ; Complement Membrane Attack Complex ; Complement System Proteins/metabolism

المؤلفون: Makkawi S; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; Department of Neurosciences, Ministry of The National Guard-Health Affairs, Jeddah, Saudi Arabia. Electronic address: serajmakkawi@gmail.com., Salamatullah HK; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Alkhiri A; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Faidah DE; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Afif LM; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Bukhari JI; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Abulaban A; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Neurology Division, Department of Medicine, Ministry of The National Guard-Health Affairs, Riyadh, Saudi Arabia., Al Malik Y; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Neurology Division, Department of Medicine, Ministry of The National Guard-Health Affairs, Riyadh, Saudi Arabia., Levy M; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

المصدر: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 May; Vol. 85, pp. 105524. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Systematic Review; Meta-Analysis; Journal Article; Review

بيانات الدورية: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

مواضيع طبية MeSH: Neuromyelitis Optica*/drug therapy , Neuromyelitis Optica*/immunology , Aquaporin 4*/immunology , Aquaporin 4*/antagonists & inhibitors , Autoantibodies*/blood, Humans ; Complement C5/antagonists & inhibitors ; Complement C5/immunology ; Randomized Controlled Trials as Topic